Reiley Pharmaceuticals, Inc. — Form D
Reiley Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-24. The offering totals $400K. Industry: Pharmaceuticals.
Offering
- Filed: 2019-10-24
- Form: D
- Accession: 0001616308-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $400K
- Remaining: $400K
- Minimum investment: $3K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-351766
Issuer
- Name: Reiley Pharmaceuticals, Inc.
- CIK: 0001616308
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3749 BUCHANAN STREET, SAN FRANCISCO, CA, 94147
- Phone: 650 269-8044
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jeff Michael Dunn | Director | Santa Clara, CA |
| B Michael Silber | Executive Officer | San Francisco, CA |
| Mark Michael Reiley | Promoter | Washington, DC |
| Keith Michael Valentine | Director | San Francisco, CA |
| Jeffrey Michael Dunn | Director | San Francisco, CA |
| B. Michael Silber | Director | San Francisco, CA |
| B. Michael Silber | Executive Officer | San Francisco, CA |
| Donald Michael Kiepert | Director | San Francisco, CA |
| Donald Michael Kiepert | Executive Officer | San Francisco, CA |
Other filings by this issuer (7)
More